SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ANDRX-Reaffirm Outperform Recommendation-Gruntal Research
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Silverman who wrote (17)12/18/1996 10:32:00 PM
From: PAUL ROBERT ST. ONGE   of 23
 
I do not have any contacts at Andrx, although it would be nice. Andrx is a screaming buy at $30, although most do not know it. Do not wait too long, when the story is very good, the prices will be quite high. Although I suspect you will wait, based on your messages and some of your biotech luck. The only concern I have long term for Andrx is a horrible decline and bear market. Im not counting on both!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News